Jai N. Patel, PharmD, CPP

I have a broad background in pharmacy, pharmaceutical sciences, and pharmacology with specific training and expertise in cancer pharmacology and pharmacogenomics. I completed a postdoctoral oncology pharmacogenomics fellowship in 2013 with Dr/Prof. Howard McLeod at the UNC Center for Pharmacogenomics and Individualized Therapy. In my current position, I oversee the cancer pharmacology & pharmacogenomics program across Atrium Health Levine Cancer Institute and Wake Forest Baptist Comprehensive Cancer Center and serve as Associate Director of Shared Resource Management at the Comprehensive Cancer Center, providing oversight for nine shared resources. My translational research program focuses on the discovery and validation of genetic predictors of drug response and drug toxicities related to cancer and supportive care therapies. I also serve as principal investigator on multiple pharmacogenomic and supportive oncology clinical trials with a focus on demonstrating clinical utility of pharmacogenomic testing. My team also oversees the clinical implementation of pharmacogenomic testing across the health system enterprise. I have experience conducting Phase I, II, and III clinical trials, including a Phase III trial published in the New England Journal of Medicine. I have published over 150 articles, editorials, book chapters, and abstracts on pharmacology, pharmacogenomics, and pharmaceutical sciences. I serve as Pharmacology Editor for HemOnc Today and Deputy Associate Editor for Supportive Care in Cancer.